SANTA CLARA, Calif., April 18, 2011 /PRNewswire/ -- NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic technology provider, announced today that Vincent Renz, President and Chief Executive Officer, will participate in the Benchmark Company, LLC One-on-One Investor Conference on Thursday, May 12, 2011 at The Pfister Hotel, 424 East Wisconsin Ave., Milwaukee, Wis. The conference will include a number of one-on-one meetings arranged by Benchmark with investors. Investors planning to attend the conference should contact their Benchmark representative to arrange a meeting.
About The Benchmark Company, LLC
Headquartered in New York City, The Benchmark Company, LLC is an institutional brokerage firm with a strong sales/trading presence in addition to its rapidly expanding research and investment banking arms. In just nine years, Benchmark has established offices in 12 cities throughout the country.
About NewCardio, Inc.
NewCardio is a cardiac diagnostic and services company developing and marketing proprietary software platform technologies to provide higher accuracy to, and increase the value of, the standard 12L ECG. NewCardio’s 3-D ECG software platform reduces the time and expense involved in assessing cardiac status while increasing the ability to diagnose clinically significant conditions which were previously difficult to detect. NewCardio’s software products and services significantly improve the diagnosis and monitoring of cardiovascular disease, as well as cardiac safety assessment of drugs under development. For more information, visit www.newcardio.com.
To join our email distribution please click this link: http://www.b2i.us/irpass.asp?BzID=1645&to=ea&s=0
Investor Contact:
Hayden IR
Jeff Stanlis, Partner
(602) 476-1821
jeff@haydenir.com
SOURCE NewCardio, Inc.
